Rare diseases
Investigational molecules
Locations
Back to Czechia27 clinical trials in Hodonin, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
CzechiaCzechiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
CzechiaA Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaKAI-9531 in Adults With Obesity or Overweight and Diabetes
CzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
CzechiaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on atherosclerotic cardiovascular disease prevention and treatment, including studies of innovative therapies for reducing major adverse cardiovascular events.
Multiple trials evaluating novel compounds for preventing heart attacks and strokes in high-risk populations.
Advanced research into treatments for various lipid disorders, with emphasis on hypertriglyceridemia and cholesterol management using cutting-edge therapeutic approaches.
Studies examining both severe and moderate forms of lipid disorders with novel therapeutic agents.
Innovative research addressing chronic venous ulcers and vascular complications, including stem cell therapies and advanced treatment modalities.
Comprehensive studies exploring both preventive measures and therapeutic interventions for vascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
